drugset
drugset / Trial / NCT04863365

A Study of Efficacy and Safety of PHP-201 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

NCT04863365 ↗

Phase 3 Unknown 110 enrolled pH Pharma
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a phase 3 study to confirm the efficacy in reduction of intraocular pressure and safety of PHP-201 ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension.

Timeline

Start
2021-11
Primary completion
2023-11
Completion
2023-11

Drugs

EvaluationDrugModalityDoseRoute
Subject AMA0076 Unknown 0.5 % Topical

Indications

ocular hypertension open-angle glaucoma